Art. 80 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 28 Jan 2022cited 11×

To ensure an appropriate level of transparency, the Management Board shall, on the basis of a proposal by the Executive Director and in agreement with the Commission, adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of medicinal products for human use and of veterinary medicinal products which is not of a confidential nature.

The internal rules and procedures of the Agency, its committees and its working groups shall be made available to the public at the Agency and on the Internet.

The 10 that are cited most themselves, of 11.

  • Ordonnance du président du Tribunal du 25 avril 2013. AbbVie, Inc. et AbbVie Ltd contre Agence européenne des médicaments.Decision

    Under the first paragraph of Article 80 of Regulation No 726/2004, the EMA is to adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of …

    25 Apr 2013 · 62013TO0044

  • Order of the Vice-President of the Court of 28 November 2013. European Medicines Agency v AbbVie, Inc. and AbbVie Ltd.Decision

    … by any of those exceptions, the remaining parts of the document are to be released. 5 Under the first paragraph of Article 80 of Regulation No 726/2004, the EMA is to adopt rules to ensure the availability to the public of regulatory, …

    28 Nov 2013 · 62013CO0389

  • Ordonnance du président du Tribunal du 25 avril 2013. InterMune UK Ltd e.a. contre Agence européenne des médicaments.Decision

    The applicants again note the requirements for protecting business secrets resulting, inter alia, from Article 80 of Regulation No 726/2004, under which information on supervision of medicinal products is to be made available to the …

    25 Apr 2013 · 62013TO0073

  • Order of the President of the General Court of 1 September 2015 (Extracts). Pari Pharma GmbH v European Medicines Agency.Decision

    … Освен това съгласно член 80, първа алинея от Регламент № 726/2004 EMA приема правила за предоставяне на разположение на обществеността …

    1 Sep 2015 · 62015TO0235(01)

  • Ordonnance du président du Tribunal du 20 juillet 2016. PTC Therapeutics International Ltd contre Agence européenne des médicaments.Decision

    … is not possible to qualify as clearly incorrect the applicant’s argument that those regulations — in particular, Articles 11, 12(3), 13(3), 14(11), 24, 26, 57(1), point (1), 57(2), 76 and 80 of Regulation No 726/2004, Article 4(7) of …

    20 Jul 2016 · 62015TO0718(02)

  • Order of the Vice-President of the Court of 28 November 2013. European Medicines Agency (EMA) v InterMune UK Ltd and Others.Decision

    Under the first paragraph of Article 80 of Regulation No 726/2004, the EMA is to adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of …

    28 Nov 2013 · 62013CO0390

  • Order of the Vice-President of the Court of 1 March 2017. European Medicines Agency (EMA) v PTC Therapeutics International Ltd.Decision

    … Article 80 of Regulation No 726/2004 provides, moreover, that the EMA is to adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of medicinal …

    1 Mar 2017 · 62016CO0513

  • Ordonnance du président du Tribunal du 20 juillet 2016. MSD Animal Health Innovation GmbH et Intervet international BV contre Agence européeDecision

    … of an MA file for a veterinary medicinal product, the applicants’ claim that those texts — namely, inter alia, Articles 36, 37(3), 38(3), 57(1), point l, 57(2), 76 and 80 of Regulation No 726/2004 and Articles 13 and 76 of Directive …

    20 Jul 2016 · 62015TO0729

  • Order of the Vice-President of the Court of 1 March 2017. European Medicines Agency (EMA) v MSD Animal Health Innovation GmbH and Intervet iDecision

    The existence of such a presumption follows from the system established by the sector-specific legislation applicable to marketing authorisation for veterinary medicinal products, in particular by Article 36, Article 37(3), Article 38(3) …

    1 Mar 2017 · 62016CO0512

  • Regulation (EU) 2019/5Lawamends